JW Therapeutics pre-markets Hong Kong IPO

Jonathan Breen

October 20, 2020 06:15 am

JW (Cayman) Therapeutics has launched pre-deal investor education for its Hong Kong IPO, setting the final stage of the deal ahead of launch in motion.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login

Topics

CITIC Securities Equity IPOs UBS Equity China China International Capital Corp Hong Kong SAR ICBC Asia Greater China Northeast Asia Shanghai Pudong Development Bank Asia Pacific Emerging Markets Goldman Sachs

JB

Jonathan Breen

Equities editor GlobalCapital Asia